Morphea in patients with psoriasis treated with ustekinumab: a scoping review

Arch Dermatol Res. 2024 Jul 27;316(8):492. doi: 10.1007/s00403-024-03236-1.

Authors

Dea Metko¹, Shanti Mehta², Ron Vender³

Affiliations

¹ Michael G. DeGroote School of Medicine, McMaster University, 90 Main St W, Hamilton, ON, L8P 1H6, Canada. [email protected].
² Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
³ McMaster University, Hamilton, ON, Canada.

PMID: 39066922
DOI: 10.1007/s00403-024-03236-1

No abstract available

Publication types

Letter
Review

MeSH terms

Dermatologic Agents / adverse effects
Dermatologic Agents / therapeutic use
Humans
Psoriasis* / drug therapy
Scleroderma, Localized* / diagnosis
Scleroderma, Localized* / drug therapy
Treatment Outcome
Ustekinumab* / adverse effects
Ustekinumab* / therapeutic use

Substances

Ustekinumab
Dermatologic Agents